These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3496658)

  • 1. Functional and anatomical brain imaging: impact on schizophrenia research.
    Buchsbaum MS; Haier RJ
    Schizophr Bull; 1987; 13(1):115-32. PubMed ID: 3496658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates.
    Wiesel FA; Wik G; Sjögren I; Blomqvist G; Greitz T; Stone-Elander S
    Acta Psychiatr Scand; 1987 Dec; 76(6):628-41. PubMed ID: 3502060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimaging studies of schizophrenia.
    Pfefferbaum A; Zipursky RB
    Schizophr Res; 1991; 4(2):193-208. PubMed ID: 2039761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Genain Quadruplets: electrophysiological, positron emission, and X-ray tomographic studies.
    Buchsbaum MS; Mirsky AF; DeLisi LE; Morihisa J; Karson CN; Mendelson WB; King AC; Johnson J; Kessler R
    Psychiatry Res; 1984 Sep; 13(1):95-108. PubMed ID: 6334864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography and subcortical glucose metabolism in schizophrenia.
    Resnick SM; Gur RE; Alavi A; Gur RC; Reivich M
    Psychiatry Res; 1988 Apr; 24(1):1-11. PubMed ID: 2899331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia.
    Buchsbaum MS
    Schizophr Bull; 1990; 16(3):379-89. PubMed ID: 2287929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced regional brain glucose metabolism assessed by positron emission tomography in electrodermal nonresponder schizophrenics: a pilot study.
    Hazlett EA; Dawson ME; Buchsbaum MS; Nuechterlein KH
    J Abnorm Psychol; 1993 Feb; 102(1):39-46. PubMed ID: 8436698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diminished cerebral metabolic response to motor stimulation in schizophrenics: a PET study.
    Guenther W; Brodie JD; Bartlett EJ; Dewey SL; Henn FA; Volkow ND; Alper K; Wolkin A; Cancro R; Wolf AP
    Eur Arch Psychiatry Clin Neurosci; 1994; 244(3):115-25. PubMed ID: 7803524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
    Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
    Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of antipsychotic treatment on cerebral structure and function in schizophrenia.
    Vita A; De Peri L
    Int Rev Psychiatry; 2007 Aug; 19(4):429-36. PubMed ID: 17671875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Examination of psychological functions by functional imaging with positron emission tomography and magnetic resonance imaging].
    Schneider F; Grodd W; Machulla HJ
    Nervenarzt; 1996 Sep; 67(9):721-9. PubMed ID: 8992369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of regional cerebral blood flow corrected for partial volume effect using O-15 water and PET: I. Theory, error analysis, and stereologic comparison.
    Iida H; Law I; Pakkenberg B; Krarup-Hansen A; Eberl S; Holm S; Hansen AK; Gundersen HJ; Thomsen C; Svarer C; Ring P; Friberg L; Paulson OB
    J Cereb Blood Flow Metab; 2000 Aug; 20(8):1237-51. PubMed ID: 10950386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psychopathology of schizophrenia and brain imaging].
    Gross G; Huber G
    Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S49-56. PubMed ID: 18461545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional brain imaging in schizophrenia.
    Cleghorn JM; Zipursky RB; List SJ
    J Psychiatry Neurosci; 1991 Jul; 16(2):53-74. PubMed ID: 1911736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative glucose metabolic rate higher in white matter in patients with schizophrenia.
    Buchsbaum MS; Buchsbaum BR; Hazlett EA; Haznedar MM; Newmark R; Tang CY; Hof PR
    Am J Psychiatry; 2007 Jul; 164(7):1072-81. PubMed ID: 17606659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroimaging in schizophrenia research.
    Gur RE; Pearlson GD
    Schizophr Bull; 1993; 19(2):337-53. PubMed ID: 8322037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities in midline attentional circuitry in schizophrenia: evidence from magnetic resonance and positron emission tomography.
    Andreasen NC; Swayze V; O'Leary DS; Nopoulos P; Cizadlo T; Harris G; Arndt S; Flaum M
    Eur Neuropsychopharmacol; 1995; 5 Suppl():37-41. PubMed ID: 8775757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual imaging in psychiatry.
    Brown RP; Kneeland B
    Hosp Community Psychiatry; 1985 May; 36(5):489-96. PubMed ID: 3874139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etiology and expression of schizophrenia: neurobiological and psychosocial factors.
    Mirsky AF; Duncan CC
    Annu Rev Psychol; 1986; 37():291-319. PubMed ID: 3485954
    [No Abstract]   [Full Text] [Related]  

  • 20. Regional cerebral blood flow changes associated with risperidone treatment in elderly schizophrenia patients: a pilot study.
    Berman I; Merson A; Sison C; Allan E; Schaefer C; Loberboym M; Losonczy MF
    Psychopharmacol Bull; 1996; 32(1):95-100. PubMed ID: 8927682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.